Shigeru Tsuyuki
About
In The Last Decade
Shigeru Tsuyuki
30 papers receiving 370 citations
Peers
Comparison fields: 5 of 68
- Oncology 163
- Cancer Research 80
- Molecular Biology 79
- Dermatology 77
- Immunology 73
Countries citing papers authored by Shigeru Tsuyuki
This map shows the geographic impact of Shigeru Tsuyuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeru Tsuyuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeru Tsuyuki more than expected).
Fields of papers citing papers by Shigeru Tsuyuki
This network shows the impact of papers produced by Shigeru Tsuyuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeru Tsuyuki. The network helps show where Shigeru Tsuyuki may publish in the future.
Co-authorship network of co-authors of Shigeru Tsuyuki
This figure shows the co-authorship network connecting the top 25 collaborators of Shigeru Tsuyuki. A scholar is included among the top collaborators of Shigeru Tsuyuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeru Tsuyuki. Shigeru Tsuyuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 3 | |
| 3 | [Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel as Neoadjuvant Chemotherapy in Breast Cancer Patients]. | 1 |
| 4 | 3 | |
| 5 | 60 | |
| 6 | 19 | |
| 7 | 7 | |
| 8 | 30 | |
| 9 | 58 | |
| 10 | [More effective positioning of capecitabine for advanced and metastatic breast cancer]. | 3 |
| 11 | 25 | |
| 12 | 1 | |
| 13 | 8 | |
| 14 | 18 | |
| 15 | 16 | |
| 16 | 2 | |
| 17 | 6 | |
| 18 | 13 | |
| 19 | 8 | |
| 20 | Liver cirrhosis induces the suppression of the cytotoxicity, but the enhancement of the proliferative response in the hepatic sinusoidal mononuclear cells. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.